Benitec Biopharma Inc.BNTCNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average, structural decline.
Left:
||||
Free cash flow yield
Latest
-5.57%
↑ 89% above average
Average (9y)
-50.40%
Historical baseline
Range
High:11.39%
Low:-320.15%
CAGR
-22.7%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2025 | -5.57% | +78.8% |
| 2024 | -26.29% | +91.8% |
| 2023 | -320.15% | -662.9% |
| 2022 | -41.97% | -134.8% |
| 2021 | -17.88% | +24.3% |
| 2020 | -23.61% | -307.3% |
| 2019 | 11.39% | +210.8% |
| 2018 | -10.28% | +20.9% |
| 2017 | -13.00% | +77.1% |
| 2016 | -56.70% | - |